Zimmer Biomet Holdings, Inc. (ZBH) is a Healthcare stock trading at $88.02 (as of 2026-06-18), with a market capitalization of $16.20B and a trailing P/E of 21.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Zimmer Biomet Holdings, together with its subsidiaries, develops, manufactures, and markets musculoskeletal healthcare products for treating disorders and injuries affecting bones, joints, and supporting soft tissues. Its offerings span orthopaedic reconstructive (e.g., knee and hip), S.E.T., spine, face and skull reconstruction, chest fixation and stabilization, and dental, serving orthopedic and related surgeons, dentists, hospitals, distributors, and healthcare dealers across multiple regions.